Children (Basel). 2020 Dec 17;7(12):305. doi: 10.3390/children7120305. MedlinePlus. Fexofenadine. Food and Drug Administration. Zyrtec (cetirizine hydrochloride) tablets and syrup for oral use. UW ...
Shares of IT company HCL Tech on Tuesday (January 14, 2025) slumped nearly 10% after the company's December quarter earnings failed to cheer investors. The stock tanked 9.41% to ₹1,798.40 on the ...
New Delhi, Shares of IT company HCL Tech on Tuesday slumped nearly 10 per cent after the company's December quarter earnings failed to cheer investors. The stock tanked 9.41 per cent to ₹1,798. ...
Mind-body therapies like meditation, psychotherapy, and deep breathing may help reduce stress levels, potentially reducing ...
HCL Technologies Ltd (HCL Tech ... "We previously argued HCLT should trade at a roughly 10 per cent premium to Infosys. This was owing to its superior outperformance to its peers over the past ...
In a knee-jerk reaction to its quarter earnings for the December 2024 quarter, Shares of HCL Technologies Ltd cracked more than 9 per cent during the trading session on Tuesday on the back of ...
If you’re looking to refinance—or in some cases buy a new home—a 10-year mortgage might be a good option for you. Here are the current 10-year mortgage rates and how you can find the right ...
Alfuzosin is contraindicated in patients with a hypersensitivity to alfuzosin or other quinazolones. Alfuzosin should be used cautiously in patients who are predisposed to hypotension, including ...
Any of the newer antihistamines, such as loratadine (Claritin, Alavert), desloratadine (Clarinex), cetirizine (Zyrtec), levocetirizine (Xyzal) and fexofenadine (Allegra), shouldn't make you feel ...
Cinacalcet for the treatment of secondary hyperparathyroidism in patients with end-stage renal disease on maintenance dialysis therapy TA117 24 January 2007 24 January 2007 Methadone and buprenorphine ...
During the year, the company launched Cetzine (Cetirizine; anti-histamine), Zimig ... has allotted fully paid up equity shares of Rs 10 each during the quarter ended 30th September 2018, pursuant ...